Research output per year
Research output per year
Personal profile
Headline
ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology
Biography
Fingerprint
Dive into the research topics where Hearn Cho is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial
Richard, S., Lesokhin, A. M., Paul, B., Kaufman, J. L., Pianko, M., Biran, N., Vij, R., Doxie, D. B., Azeem, M. I., Martillo, M., Wozniak, K., Cho, H. J., Dhodapkar, K. M. & Dhodapkar, M. V., Oct 2024, In: Nature Cancer. 5, 10, p. 1459-1464 6 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Creating Equitable and Inclusive Clinical Trials for Multiple Myeloma
Hartley-Brown, M., Cole, C. E., Price, P., Andreini, M., Mulligan, G., Young, A. Q. & Cho, H. J., Jan 2024, In: Clinical Lymphoma, Myeloma and Leukemia. 24, 1, p. 32-39 8 p.Research output: Contribution to journal › Short survey › peer-review
Open Access3 Scopus citations -
Modernizing multiple myeloma clinical trial eligibility to improve equity and inclusivity by hematological parameters
Merz, L., Hartley-Brown, M., Achebe, M., Cole, C., Kanapuru, B., Banjo, O., Mulligan, G., Wozniak, K., Young, A. Q. & Cho, H. J., 2024, (Accepted/In press) In: Seminars in Hematology.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Bridging advanced myeloma patients to subsequent treatments and clinical trials with classical chemotherapy and stem cell support
Mouhieddine, T. H., Moshier, E., Thibaud, S., Puliafito, B., Rattu, M., Jakubowski, R., Sanchez, L., Rossi, A., Rodriguez, C., Richard, S., Cho, H. J., Parekh, S., Chari, A., Steinberg, A. & Richter, J., Jan 2023, In: Bone Marrow Transplantation. 58, 1, p. 80-86 7 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma
PVI/MM/Seronet Study Group, Dec 2023, In: eBioMedicine. 98, 104886.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations
Press/Media
-
-
Reports from Icahn School of Medicine at Mount Sinai Describe Recent Advances in Multiple Myeloma (High Dimensional Immune Profiling of Smoldering Multiple Myeloma Distinguishes Distinct Tumor Microenvironments)
Kim-Schulze, S., Rahman, A., Parekh, S., Cho, H. & Gnjatic, S.
11/09/23
1 item of Media coverage
Press/Media
-
Study Data from Icahn School of Medicine at Mount Sinai Update Knowledge of Multiple Myeloma (Bortezomib-Induced Reticular Eruption in Patient with Multiple Myeloma)
Cho, H., Gulati, N. & Niedt, G.
9/08/23
1 item of Media coverage
Press/Media